Skip to Content


by Emily Mullin, quoting I. Glenn Cohen (Faculty Director)
STAT
January 24, 2019

Read the Full Article

From the article:

"I. Glenn Cohen, a Harvard health law professor, said this new trial, as well as Zhang’s travel to Mexico for mitochondrial replacement therapy, may put pressure on the U.S. and other countries to change their policies for mitochondrial replacement therapy, noting these cases open the door to medical tourism.

'There is simply no way for any country to truly insulate itself from alterations through mitochondrial replacement therapy entering a country’s gene pool,' Cohen said."

Read more here!

Read the Full Article

Tags

bioethics   biotechnology   i. glenn cohen